Yearly Archives: 2025

/2025

Reflections on Pharmacy First: One Year On

The post Reflections on Pharmacy First: One Year On appeared first on Community Pharmacy England.

By |January 31st, 2025|Lexpos News|Comments Off on Reflections on Pharmacy First: One Year On

Reactivation of SSP078 for Cefalexin 250mg/5ml oral suspension sugar free

Update 08/05/25 – The Department of Health and Social Care (DHSC) has provided an update on the Serious Shortage Protocol (SSP) for Cefalexin 250mg/5ml oral suspension sugar free (SSP078), which has been reactivated due to supply issues. SSP078 is now due to expire on Friday 8 August 2025. Community Pharmacy England’s in-house Drug Tariff and [...]

The post Reactivation of SSP078 for Cefalexin 250mg/5ml oral suspension sugar free appeared first on Community Pharmacy England.

By |January 31st, 2025|Lexpos News|Comments Off on Reactivation of SSP078 for Cefalexin 250mg/5ml oral suspension sugar free

Funding & Reimbursement Shorts: ‘FS’ endorsed prescriptions for free supply of sexual health treatments

As part of our Funding & Reimbursement Shorts series Community Pharmacy England’s in-house Drug Tariff and funding experts have created a new video providing guidance on how handling ‘FS’ endorsed prescriptions for free supply of sexual health treatments. In our latest video, Mitesh Bhudia and Gemma Hackett from our Dispensing and Supply Team, discuss the [...]

The post Funding & Reimbursement Shorts: ‘FS’ endorsed prescriptions for free supply of sexual health treatments appeared first on Community Pharmacy England.

By |January 31st, 2025|Lexpos News|Comments Off on Funding & Reimbursement Shorts: ‘FS’ endorsed prescriptions for free supply of sexual health treatments

MHRA Class 2 Medicines Recall: Amlodipine Bristol Lab 2.5mg tablets (Bristol Laboratories Limited)

Drug alert number: EL (25)A/04 Date issued: 30 January 2025 Bristol Laboratories Limited is recalling the batches specified in the table as a precautionary measure due to possible microbial contamination. Amlodipine Bristol Lab 2.5 mg Tablets, PL 17907/0435 SNOMED Code: 38095611000001108 Batch Number Expiry Date Pack Size First Distributed MF23016 July 2025 28 29/9/2023 MF23017 [...]

The post MHRA Class 2 Medicines Recall: Amlodipine Bristol Lab 2.5mg tablets (Bristol Laboratories Limited) appeared first on Community Pharmacy England.

By |January 30th, 2025|Lexpos News|Comments Off on MHRA Class 2 Medicines Recall: Amlodipine Bristol Lab 2.5mg tablets (Bristol Laboratories Limited)

January 2025 Price Concessions: 4th Update

Following discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (30/01/2025) announced the following list of price concessions for January 2025. Following representations made by Community Pharmacy England on behalf of community pharmacy owners, the Department of Health [...]

The post January 2025 Price Concessions: 4th Update appeared first on Community Pharmacy England.

By |January 30th, 2025|Lexpos News|Comments Off on January 2025 Price Concessions: 4th Update